The supply of a small variety of vaccine doses from Pfizer to a number of international locations within the European Union suffered a minor delay after considerations in regards to the temperature controls getting used to maintain the doses tremendous chilly. The difficulty pressured shipments from a manufacturing unit in Belgium to be pushed again a day, in line with the Spanish well being authorities.
Pfizer’s manufacturing unit in Puurs, Belgium, advised the corporate’s Spanish division on Monday night time that shipments to eight European international locations could be delayed “due to an issue within the technique of loading and sending,” the Spanish ministry stated in a information launch.
The discharge didn’t specify which international locations beside Spain had been affected. When requested in regards to the delay on the Spanish radio broadcaster Ser, Salvador Illa, the well being minister, stated that the issue was linked to the “management of the temperature” of the shipments and had been resolved.
The doses, he stated, ought to arrive on Tuesday, sooner or later late.
A Pfizer spokeswoman, nevertheless, stated that whereas there was a “minor logistical situation,” there have been “no manufacturing or temperature management points to report.”
The delay underscored the logistical challenges of rushing hundreds of thousands of doses of vaccine that must be saved at minus 70 levels Celsius world wide as quick as potential.
On Sunday, the primary day of the vaccination marketing campaign in Europe, there was additionally a minor drawback with the cold-chain course of in Germany: Issues about 1,000 photographs not being chilly sufficient delayed efforts round Lichtenfels, in Bavaria.
“When studying the temperature loggers that had been enclosed within the cool packing containers, doubts arose in regards to the compliance with the chilly chain necessities,” the district of Lichtenfels stated in an announcement.
By late Sunday, the issues had been resolved and the marketing campaign commenced.